Claims
- Decreases the frequency of coughs within the initial days of treatment
- Relieves throat irritation within the first two hours of application
- Eases chest discomfort caused by coughing
- Reduces nighttime disturbances associated with coughing
- Lowers the need for antibiotics
- Enhances the patient's quality of life
- Promotes better sleep
- Improves overall well-being
- Well tolerated with no side effects
Mode of Action
The unique formulation of Cough Kids targets throat irritation, and throat mucus accuumulation to deliver relief and soothing effects. Its mechanism of action operates through three key pathways:
Protective Barrier Effect: Cough Kids forms a thin, protective film over the throat mucosa, regulating mucus adhesion in wet cough while shielding the irritated mucosa in dry cough. This barrier helps reduce throat discomfort and supports natural symptom relief.
Osmotic and Cleaning Effect: The product's high osmotic activity helps optimize mucus consistency in wet cough, facilitating natural clearance, while in dry cough, it maintains hydration, alleviating throat dryness and irritation.
Cellular Repair and Growth Effect: By creating a clean and hydrated biological surface, Cough Kids immediately triggers cell growth and healing. This helps restore the integrity of the throat mucosa, further alleviating symptoms and promoting recovery
.
A Safe and Effective Solution
Cough Kids is a safe and effective solution for managing acute wet and dry cough in children. Its unique action not only helps to relieve the symptoms but also supports the natural healing processes of the body, making it an excellent choice for parents seeking a comprehensive approach to their child’s cough treatment.
Clinical Trial
The efficacy of Cough Kids was confirmed in a randomized, double-blind, placebo-controlled trial conducted over two weeks. The study involved 30 patients, with 20 receiving the test product and 10 receiving the comparator (a saline solution).
The results demonstrated the effectiveness of Cough Kids in reducing cough frequency within just a few days, relieving throat irritation within two hours of the first application, alleviating chest discomfort, improving nighttime disturbances, and decreasing the need for antibiotics.
Main results
- Cough frequency
After 3 days of treatment, the group treated with the topical polymeric film COUGHKIDS (TP group) experienced a 45.79% reduction in cough frequency, compared to the baseline.
By day 6, the reduction in cough frequency in the TP group increased to 89.71%, and by day 15, it reached 98.13%.
- Chest discomfort
After three days of treatment, the group treated with Cough Kids experienced significant improvements in chest discomfort caused by coughing, with these reductions sustained through days 6 and 15.
By the end of the study, chest discomfort was reduced by 97.01% in the investigational group compared to 61.67% in the control group.
- Sleep disturbances
Sleep disturbances due to night coughing were significantly reduced in the TP group, with a 55.56% reduction observed by day 3, 75.76% by day 6, and 97.98% by day 15.
- Throat irritation
Throat irritation was significantly reduced in the TP group, with noticeable improvement starting as early as 2 hours after application. A reduction of 66% was observed by day 3, 88% by day 6, and 98% by day 15.
- Quality of life
The Quality of Life (QOL) score improved significantly in the TP group after 14 days of treatment, showing a marked improvement from a baseline score of 19.77 to 41.60 by the end of the study, compared to a limited increase from 19.10 to 23.30 in the comparator group
- Antibiotics Usage
None of the patients in the test product group required antibiotics, while 40% of the comparator group required antibiotic treatment.
In conclusion, COUGHKIDS has shown promising results in clinical trials. The treatment was found to significantly suppress cough symptoms within just three days of application, reducing the need for antibiotics.
This is particularly noteworthy given the growing concern about antibiotic resistance and the side effects of chemical cough treatments. The fact that no adverse effects were reported during the trial further underscores the safety of this treatment.
Overall, this innovative approach to treating acute wet and dry cough in children could potentially offer a safe, effective, and non-chemical alternative to traditional cough treatments, providing a new option for parents and healthcare providers in managing this common childhood ailment.
Product Details
- Indication: Used for the treatment of acute wet and dry cough in children aged three years and older.
- Composition: Glycerol, Aqua, Honey, CD-Cyanidin-E (derived from extracts of Ribes nigrum fruit and Curcuma longa)
- Presentation: Throat spray 20ml.
- Class: MDR Class IIa.
- Direction: Apply 4 sprays in the throat, 3 times a day.
- Precautions: For topical use only (oral cavity).
- Exclusions: Cough Kids should not be used in patients diagnosed with lower respiratory tract diseases such as laryngitis, tracheitis, bronchitis, pneumonia, asthma, sinusitis, allergic rhinitis, or heart disease. It is also not suitable for individuals experiencing a chronic cough, or chronic dysphagia.
- Age: Suitable for children aged 3 years and over.
- Storage conditions: Below 25°C.
- Legal manufacturer: VITROBIO (France).
- Product code: CE.